View printer-friendly version << Back
MEDNAX Announces Acquisition of Anesthesiology Practice in Texas

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--May. 30, 2013-- MEDNAX, Inc., (NYSE:MD) today announced the acquisition of Anesthesia Specialists of Houston, L.L.P., a physician group practice based in Houston, Texas. The practice will become part of MEDNAX’s American Anesthesiology division and is the third Texas-based anesthesiology practice to join this division.

Anesthesia Specialists of Houston has been serving the Greater Houston metropolitan area since 1981 and is a private group practice consisting of 9 anesthesiologists, 30 anesthetists and 9 other clinical and administrative support staff. The practice provides anesthesia services at The Woman's Hospital of Texas, which is dedicated solely to the health of women and newborns, as well as at Fannin Surgicare, an outpatient ambulatory surgical center.

MEDNAX’s Pediatrix Medical Group division currently provides neonatal intensive care services at The Woman's Hospital of Texas.

“We wanted to be part of American Anesthesiology for reasons that go beyond the many challenges we face in the future of healthcare,” said Hector Santiago, M.D., who will serve as medical director for the practice. “Not only does MEDNAX already have an excellent relationship with The Woman’s Hospital of Texas through their NICU, but the company’s unparalleled experience and resources, and the fact that its physicians and leadership place a high value on clinical research, education and quality is what convinced us that we found the right partner.”

MEDNAX’s American Anesthesiology division consists of more than 1,600 anesthesia providers, including more than 650 physicians and 950 anesthetists practicing in North Carolina, Florida, Georgia, Michigan, New Jersey, Tennessee, Texas, and Virginia.

This practice was acquired for cash and the transaction is expected to be immediately accretive to earnings. No additional terms of the transaction were disclosed.


MEDNAX, Inc. is a national medical group that comprises the nation's leading provider of neonatal, maternal-fetal and pediatric physician subspecialty services as well as anesthesia services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was founded in 1979 and now includes neonatal physicians who provide services at more than 330 neonatal intensive care units, who collaborate with affiliated maternal-fetal medicine, pediatric cardiology and pediatric critical care physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation's largest provider of newborn hearing screens. In 2007, MEDNAX expanded into anesthesia services. Today, American Anesthesiology includes more than 1,600 anesthesiologists and advanced practitioners who provide anesthesia care to patients in connection with surgical and other procedures as well as pain management. MEDNAX, through its affiliated professional corporations, employs more than 2,150 physicians in 34 states and Puerto Rico. Additional information is available at

Certain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”, “will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and similar expressions, and are based on assumptions and assessments made by MEDNAX’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX’s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s current reports on Form 8-K, filed with the Securities and Exchange Commission.

Source: MEDNAX, Inc.

David T. Parker, 954-384-0175, Ext. 5300
Vice President, Investor Relations & Corporate Communications